Project Grant R21AI199873
Award Date 6/23/26
Completion Date 5/31/28
Dollars Obligated $270K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Scripps Research Institute a $506,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 9, 2025, with a completion date of June 30, 2027. The award supports the development of high-throughput technologies for generating and screening small interfering RNA (siRNA)-peptide conjugates designed to improve delivery efficiency for viral infection...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Scripps Research Institute a $919,605 Project Grant on June 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This grant supports antibody-guided vaccine development research targeting human astrovirus (HAstV), a leading cause of viral diarrhea in children and a significant public health concern globally. The project will deliver comprehensive monoclonal...
- Federal Project Grant Award Summary The Scripps Research Institute received a $1,379,954 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 21, 2025, with completion targeted for July 31, 2030. The award supports systematic research to engineer durable immunity through optimization of Human Immunodeficiency Virus (HIV) vaccine parameters designed to drive...
- Federal Project Grant Summary Award Information: The National Institute of Allergy and Infectious Diseases (NIAID) awarded $899,741 to Scripps Research Institute through the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 1, 2026, with a completion date of March 31, 2031. Products and Services: Under this five-year Project Grant, Scripps Research Institute will develop a long-acting injectable (LAI) therapy for hepatitis B virus (HBV) in individuals co-infected with human...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $438,500 Project Grant to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2027. This award funds investigator-initiated biomedical research examining the sequence-specific determinants and impacts of NS2 (nonstructural protein 2) interactions with the Influenza A Virus...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Scripps Research Institute a Project Grant totaling $931,385 under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of June 10, 2026 and completion date of May 31, 2027. The grant funds research and development of glycoengineered HIV-1 envelope (Env) vaccine immunogens incorporating core α(1,3)-fucose motifs to enhance vaccine efficacy. The...
- Federal Grant Award Summary The Scripps Research Institute received a $230,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 1, 2026 through April 30, 2028. The grant supports the development of a modular crosslinking mass spectrometry (XL-MS) platform designed to enable quantitative, proteome-wide mapping of protein-protein interactions (PPIs) in live cells without...
- Federal Grant Award Summary Award Details: The Scripps Research Institute received a $511,531 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 13, 2026 through January 31, 2031. Products and Services: This project advances HIV vaccine development by incorporating engineered transmembrane envelope (Env) glycoprotein vaccine candidates into stable lipid nanodiscs using...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Scripps Research Institute a Project Grant totaling $1,285,304 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and evaluate an enhanced HIV vaccine regimen capable of producing durable broadly neutralizing antibody (BNAB) responses. The research, which commenced August 1, 2025, and extends through July 31, 2030, leverages a novel six-shot germline-targeting...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Scripps Research Institute a $3.02 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning August 8, 2025, with a completion date of July 31, 2029. This award supports the design and development of single-shot sequential immunization regimens for HIV using atomic layer deposition (ALD) technology. The research builds upon preclinical successes...